Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease

Clinics in Chest Medicine

Volumn 36, Issue 1, 2015, Pages 43-54

  van Ingen, Jakko ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Microbiology; Nontuberculous mycobacteria; Pulmonary disease

Indexed keywords

ACID FAST BACTERIUM; ARTICLE; ASEPSIS; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL DECONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CULTURE MEDIUM; ENVIRONMENTAL EXPOSURE; HUMAN; INCUBATION TEMPERATURE; LIQUID CULTURE; LUNG INFECTION; LUNG LAVAGE; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; SEROLOGY; SOLID MEDIUM; SPECIES IDENTIFICATION; SPUTUM CULTURE; DIAGNOSTIC PROCEDURE; ISOLATION AND PURIFICATION; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PHYSICAL EXAMINATION;

BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL LABORATORY TECHNIQUES; HUMANS; LUNG DISEASES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PHYSICAL EXAMINATION;

EID: 84922465623     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.11.005     Document Type: Review

References (76)

1. van Ingen J., Bendien S.A., de Lange W.C., et al. Clinical relevance of nontuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands. Thorax 2009, 64:502-506.
2. Griffith D.E., Aksamit T., Brown-Elliot B.A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
3. Alisjahbana B., van Crevel R., Danusantoso H., et al. Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis. Int J Tuberc Lung Dis 2005, 9:814-817.
4. Wali S.O., Abdelaziz M.M., Krayem A.B., et al. The presence of atypical mycobacteria in the mouthwashes of normal subjects: role of tap water and oral hygiene. Ann Thorac Med 2008, 3:5-8.
5. Goeminne P.C., Vandooren J., Moelants E.A., et al. The sputum colour chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology 2014, 19:203-210.
6. Paramasivan C.N., Narayana A.S., Prabhakar R., et al. Effect of storage of sputum specimens at room temperature on smear and culture results. Tubercle 1983, 64:119-124.
7. Banda H.T., Harries A.D., Boeree M.J., et al. Viability of stored sputum specimens for smear microscopy and culture. Int J Tuberc Lung Dis 2000, 4:272-274.
8. Murray M.P., Doherty C.J., Govan J.R., et al. Do processing time and storage of sputum influence quantitative bacteriology in bronchiectasis?. JMed Microbiol 2010, 59:829-833.
9. Pye A., Hill S.L., Bharadwa P., et al. Effect of storage and postage on recovery and quantitation of bacteria in sputum samples. JClin Pathol 2008, 61:352-354.
10. Mase S.R., Ramsay A., Ng V., et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007, 11:485-495.
11. Tsukamura M. Diagnosis of disease caused by Mycobacterium avium complex. Chest 1991, 99:667-669.
12. Sugihara E., Hirota N., Niizeki T., et al. Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection. JInfect Chemother 2003, 9:328-332.
13. Tanaka E., Amitani R., Niimi A., et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997, 155:2041-2046.
14. Wright P.W., Wallace R.J., Wright N.W., et al. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria. JClin Microbiol 1998, 36:1046-1049.
15. Somoskövi A., Hotaling J.E., Fitzgerald M., et al. Lessons from a proficiency testing event for acid-fast microscopy. Chest 2001, 120:250-257.
16. Peres R.L., Maciel E.L., Morais C.G., et al. Comparison of two concentrations of NALC-NaOH for decontamination of sputum for mycobacterial culture. Int J Tuberc Lung Dis 2009, 13:1572-1575.
17. Buijtels P.C., Petit P.L. Comparison of NaOH-N-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimens. JMicrobiol Methods 2005, 62:83-88.
18. Whittier S., Hopfer R.L., Knowles M.R., et al. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. JClin Microbiol 1993, 31:861-864.
19. Whittier S., Olivier K., Gilligan P., et al. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. JClin Microbiol 1997, 35:2706-2708.
20. Bange F.C., Kirschner P., Böttger E.C. Recovery of mycobacteria from patients with cystic fibrosis. JClin Microbiol 1999, 37:3761-3763.
21. Bange F.C., Bottger E.C. Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2002, 21:546-548.
22. Ferroni A., Vu-Thien H., Lanotte P., et al. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. JClin Microbiol 2006, 44:2237-2239.
23. De Bel A., De Geyter D., De Schutter I., et al. Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients. JClin Microbiol 2013, 51:4204-4206.
24. Peter-Getzlaff S., Lüthy J., Voit A., et al. Detection and identification of Mycobacterium spp. in clinical specimens by combining the Roche Cobas Amplicor Mycobacterium tuberculosis assay with Mycobacterium genus detection and nucleic acid sequencing. JClin Microbiol 2010, 48(11):3943-3948.
25. Seagar A.L., Prendergast C., Emmanuel F.X., et al. Evaluation of the genotype mycobacteria direct assay for the simultaneous detection of the Mycobacterium tuberculosis complex and four atypical mycobacterial species in smear-positive respiratory specimens. JMed Microbiol 2008, 57:605-611.
26. Bicmen C., Gunduz A.T., Coskun M., et al. Molecular detection and identification of Mycobacterium tuberculosis complex and four clinically important nontuberculous mycobacterial species in smear-negative clinical samples by the genotype mycobacteria direct test. JClin Microbiol 2011, 49:2874-2878.
27. Luetkemeyer A.F., Kendall M.A., Wu X., Adult AIDS Clinical Trials Group A5255 Study Team, et al. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB mycobacteria in HIV-infected individuals with suspected TB. JClin Microbiol 2014, 52:1052-1059.
28. Cruciani M., Scarparo C., Malena M., et al. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. JClin Microbiol 2004, 42:2321-2325.
29. Chew W.K., Lasaitis R.M., Schio F.A., et al. Clinical evaluation of the Mycobacteria Growth Indicator Tube (MGIT) compared with radiometric (Bactec) and solid media for isolation of Mycobacterium species. JMed Microbiol 1998, 47:821-827.
30. Idigoras P., Beristain X., Iturzaeta A., et al. Comparison of the automated nonradiometric Bactec MGIT 960 system with Löwenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur J Clin Microbiol Infect Dis 2000, 19:350-354.
31. Sorlozano A., Soria I., Roman J., et al. Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples. JMicrobiol Biotechnol 2009, 19:1259-1264.
32. Rivera A.B., Tupasi T.E., Grimaldo E.R., et al. Rapid and improved recovery rate of Mycobacterium tuberculosis in Mycobacteria Growth Indicator Tube combined with solid Löwenstein Jensen medium. Int J Tuberc Lung Dis 1997, 1:454-459.
33. Alcaide F., Benítez M.A., Escribà J.M., et al. Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. JClin Microbiol 2000, 38:398-401.
34. Lu D., Heeren B., Dunne W.M. Comparison of the automated mycobacteria growth indicator tube system (BACTEC 960/MGIT) with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 2002, 118:542-545.
35. Lee J.J., Suo J., Lin C.B., et al. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 2003, 7:569-574.
36. Sharp S.E., Lemes M., Sierra S.G., et al. Löwenstein-Jensen media. No longer necessary for mycobacterial isolation. Am J Clin Pathol 2000, 113:770-773.
37. Hillemann D., Richter E., Rüsch-Gerdes S. Use of the BACTEC Mycobacteria Growth Indicator Tube 960 automated system for recovery of mycobacteria from 9,558 extrapulmonary specimens, including urine samples. JClin Microbiol 2006, 44:4014-4017.
38. Piersimoni C., Nista D., Bornigia S., et al. Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture system. JClin Microbiol 2009, 47:804-806.
39. Realini L., de Ridder K., Hirschel B., et al. Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect Dis 1999, 34:45-50.
40. Saubolle M.A., Kiehn T.E., White M.H., et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996, 9:435-447.
41. Hoefsloot W., van Ingen J., Peters E.J., et al. Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases. Clin Microbiol Infect 2013, 19:432-437.
42. Thomsen V.O., Dragsted U.B., Bauer J., et al. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. JClin Microbiol 1999, 37:3901-3905.
43. Coyle M.B., Carlson L.C., Wallis C.K., et al. Laboratory aspects of "Mycobacterium genavense", a proposed species isolated from AIDS patients. JClin Microbiol 1992, 30:3206-3212.
44. Swart R.M., van Ingen J., van Soolingen D., et al. Nontuberculous Mycobacterium infection and tumor necrosis factor-α antagonists. Emerg Infect Dis 2009, 15:1700-1701.
45. Bruijnesteijn van Coppenraet L.E., Kuijper E.J., Lindeboom J.A., et al. Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005, 11:62-68.
46. Moore M., Frerichs J.B. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. JInvest Dermatol 1953, 20:133-169.
47. Torkko P., Suomalainen S., Iivanainen E., et al. Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov. Int J Syst Evol Microbiol 2000, 50:283-289.
48. Alfa M.J., Manickam K., Sepehri S., et al. Evaluation of BacT/Alert 3D automated unit for detection of nontuberculous mycobacteria requiring incubation at 30 degrees C for optimal growth. JClin Microbiol 2011, 49:2691-2693.
49. Springer B., Stockman L., Teschner K., et al. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. JClin Microbiol 1996, 34:296-303.
50. De Zwaan R., van Ingen J., van Soolingen D. Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands. JClin Microbiol 2014, 52:2544-2551.
51. Roth A., Fischer M., Hamid M.E., et al. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. JClin Microbiol 1998, 36:139-147.
52. McNabb A., Eisler D., Adie K., et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. JClin Microbiol 2004, 42:3000-3011.
53. Adékambi T., Colson P., Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. JClin Microbiol 2003, 41:5699-5708.
54. Macheras E., Roux A.L., Bastian S., et al. Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. JClin Microbiol 2011, 49:491-499.
55. Zelazny A.M., Root J.M., Shea Y.R., et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. JClin Microbiol 2009, 47:1985-1995.
56. Buchan B.W., Riebe K.M., Timke M., et al. Comparison of MALDI-TOF MS with HPLC and nucleic acid sequencing for the identification of Mycobacterium species in cultures using solid medium and broth. Am J Clin Pathol 2014, 141:25-34.
57. van Ingen J., Boeree M.J., de Lange W.C., et al. Clinical relevance of Mycobacterium szulgai in the Netherlands. Clin Infect Dis 2008, 46:1200-1205.
58. Hoefsloot W., van Ingen J., de Lange W.C., et al. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 2009, 34:926-931.
59. van Ingen J., Boeree M.J., Dekhuijzen P.N., et al. Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur Respir J 2008, 31:106-109.
60. van Ingen J., de Zwaan R., Dekhuijzen R., et al. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. JInfect 2009, 59:324-331.
61. van Ingen J., Boeree M.J., de Lange W.C., et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008, 14:385-389.
62. Koh W.J., Kwon O.J., Jeon K., et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006, 129:341-348.
63. Buchholz U.T., McNeil M.M., Keyes L.E., et al. Mycobacterium malmoense infections in the United States, January 1993 through June 1995. Clin Infect Dis 1998, 27:551-558.
64. van Ingen J., Boeree M., van Soolingen D., et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012, 15:149-161.
65. Brown-Elliott B.A., Nash K.A., Wallace R.J. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012, 25:545-582.
66. Kitada S., Maekura R., Toyoshima N., et al. Use of glycopeptidolipid core antigen for serodiagnosis of Mycobacterium avium complex pulmonary disease in immunocompetent patients. Clin Diagn Lab Immunol 2005, 12:44-51.
67. Kitada S., Kobayashi K., Ichiyama S., MAC Serodiagnosis Study Group, et al. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med 2008, 177:793-797.
68. Kobashi Y., Mouri K., Obase Y., et al. Serological assay by use of glycopeptidolipid core antigen for Mycobacterium avium complex. Scand J Infect Dis 2013, 45:241-249.
69. Jeong B.H., Kim S.Y., Jeon K., et al. Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen. JClin Microbiol 2013, 51:2747-2749.
70. Shu C.C., Ato M., Wang J.T., et al. Sero-diagnosis of Mycobacterium avium complex lung disease using serum immunoglobulin A antibody against glycopeptidolipid antigen in Taiwan. PLoS One 2013, 8:e80473.
71. Kitada S., Levin A., Hiserote M., et al. Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA. Eur Respir J 2013, 42:454-460.
72. Universal principles of design 2010, 112. Rockport Publishers, Gloucester (MA), ISBN 1-59253-587-9. 2nd edition. J. Butler, W. Lidwell, K. Holden (Eds.).
73. Leber A., Marras T.K. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. Eur Respir J 2011, 37:1158-1165.
74. Ballarino G.J., Olivier K.N., Claypool R.J., et al. Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med 2009, 103:1448-1455.
75. Fraczek M.G., Kirwan M.B., Moore C.B., et al. Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR. Mycoses 2014, 57:69-78.
76. Hoefsloot W., van Ingen J., Andrejak C., Nontuberculous Mycobacteria Network European Trials Group, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013, 42:1604-1613.